# Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer

> **NCT00870532** · PHASE1 · COMPLETED · sponsor: **National Cancer Centre, Singapore** · enrollment: 52 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** oral vinorelbine
- **DRUG:** sorafenib

## Key facts

- **NCT ID:** NCT00870532
- **Lead sponsor:** National Cancer Centre, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2013-08
- **Final completion:** 2013-09
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2013-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00870532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00870532, "Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00870532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*